Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 12 | 11 |
|
Comprehensive Aortopathy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 54 | 48 |
|
Marfan and Related Conditions Panel Mayo Clinic Laboratories Mayo Clinic United States | 37 | 30 |
|
FBN2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Connective Tissue Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 195 | 92 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Marfan Syndrome and Related Aortopathies Panel PreventionGenetics, part of Exact Sciences United States | 40 | 38 |
|
HNL Genomics Connective Tissue Gene Tests United States | 3 | 3 |
|
Fibrillinopathy Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 3 |
|
Fibrillinopathy Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 3 |
|
Connective Tissue Disorders Panel PreventionGenetics, part of Exact Sciences United States | 166 | 101 |
|
Congenital contractural arachnodactyly Deletion / Duplication Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Congenital contractural arachnodactyly Comprehensive Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Congenital contractural arachnodactyly NGS Test HNL Genomics Connective Tissue Gene Tests United States | 1 | 1 |
|
Ambry Genetics United States | 50 | 35 |
|
FBN1 gene sequence and deletion/duplication reflex to TAADNext® Ambry Genetics United States | 50 | 35 |
|
Ambry Genetics United States | 236 | 167 |
|
Fibrillinopathy Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 3 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.